A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy
一项随机1期安全性、药代动力学和药效学研究：新型肌肉生长抑制素抑制剂Apitegromab（SRK-015）治疗脊髓性肌萎缩症的潜在疗法
期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-021-01757-z
Barrett, Doreen; Bilic, Sanela; Chyung, Yung; Cote, Shaun M; Iarrobino, Ryan; Kacena, Katherine; Kalra, Ashish; Long, Kimberly; Nomikos, George; Place, Amy; Still, James Gordon; Vrishabhendra, Leela
